- Home
- DTCK vs MBRX Comparison
DTCK vs MBRX Comparison
Compare DTCK & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- MBRX
- Stock Information
- Founded
- DTCK 1999
- MBRX 2015
- Country
- DTCK Singapore
- MBRX United States
- Employees
- DTCK N/A
- MBRX N/A
- Industry
- DTCK Farming/Seeds/Milling
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- DTCK Industrials
- MBRX Health Care
- Exchange
- DTCK Nasdaq
- MBRX Nasdaq
- Market Cap
- DTCK 21.9M
- MBRX 24.3M
- IPO Year
- DTCK 2023
- MBRX 2016
- Fundamental
- Price
- DTCK $0.79
- MBRX $0.51
- Analyst Decision
- DTCK
- MBRX Strong Buy
- Analyst Count
- DTCK 0
- MBRX 4
- Target Price
- DTCK N/A
- MBRX $5.00
- AVG Volume (30 Days)
- DTCK 272.4K
- MBRX 2.7M
- Earning Date
- DTCK 11-12-2025
- MBRX 11-07-2025
- Dividend Yield
- DTCK N/A
- MBRX N/A
- EPS Growth
- DTCK N/A
- MBRX N/A
- EPS
- DTCK N/A
- MBRX N/A
- Revenue
- DTCK $132,369,000.00
- MBRX N/A
- Revenue This Year
- DTCK N/A
- MBRX N/A
- Revenue Next Year
- DTCK N/A
- MBRX N/A
- P/E Ratio
- DTCK N/A
- MBRX N/A
- Revenue Growth
- DTCK N/A
- MBRX N/A
- 52 Week Low
- DTCK $0.40
- MBRX $0.25
- 52 Week High
- DTCK $1.50
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- DTCK 44.58
- MBRX 53.09
- Support Level
- DTCK $0.72
- MBRX $0.42
- Resistance Level
- DTCK $1.03
- MBRX $0.50
- Average True Range (ATR)
- DTCK 0.09
- MBRX 0.04
- MACD
- DTCK -0.00
- MBRX 0.01
- Stochastic Oscillator
- DTCK 23.37
- MBRX 57.02
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.